Telomerase inhibitory effects of medicinal mushrooms and lichens, and their anticancer activity

International Journal of Medicinal Mushrooms

Volumn 16, Issue 1, 2014, Pages 17-28

  Xu, Baojun ^a   Li, Chantian ^b   Sung, Changkeun ^c  

^a BNU HKBU UNITED INTERNATIONAL COLLEGE   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c Chungnam National University   (South Korea)

Author keywords

Anticancer activity; Lichens; Medicinal mushrooms; Telomerase inhibitor

Indexed keywords

FUNGAL EXTRACT; TAQ POLYMERASE; TELOMERASE; ANTINEOPLASTIC AGENT; PLANT EXTRACT;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; ENZYME INHIBITION; HUMAN; HUMAN CELL; IC 50; LASIOSPHAERA FENZLII; LICHEN (ORGANISM); MEDICINAL MUSHROOM; MTT ASSAY; PLEUROTUS OSTREATUS; POLYMERASE CHAIN REACTION; SARCODON ASPRATUS; STROBILOMYCES FLOCCOPUS; TELOMERIC REPEAT AMPLIFICATION PROTOCOL; UMBILICARIA ESCULENTA; AGARICALES; ANTAGONISTS AND INHIBITORS; CELL PROLIFERATION; CHEMISTRY; CLASSIFICATION; DRUG EFFECTS; MEDICINAL PLANT; METABOLISM; TUMOR CELL LINE; VEGETABLE;

AGARICALES; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; LICHENS; PLANT EXTRACTS; PLANTS, MEDICINAL; TELOMERASE; VEGETABLES;

EID: 84895816192     PISSN: 15219437     EISSN: 19404344     Source Type: Journal    
DOI: 10.1615/IntJMedMushr.v16.i1.20     Document Type: Article

References (28)

1. Morin GB. The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell. 1989;59:521-529.
2. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, Shay JW. Specifc association of human telomer-ase activity with immortal cells and cancer. Science 1994;266:2011-2015.
3. Shay JW, Wright WE. Telomerase activity in human cancer. Curr Opin Oncol. 1996;8:66-71.
4. Nelson NJ. Researchers debate clinical role of telomer-ase. J Natl Cancer Inst. 1996;88:1021-1023.
5. Shay JW, Bacchetti S. A survey of telomerase activity in human cancer. Eur J Cancer. 1997;33:787-791.
6. Naasani I, Seimiya H, Tsuruo T. Telomerase inhibition, telomere shortening, and senescence of cancer cells by tea catechins. Biochem Biophys Res Comm. 1989;43:109-116.
7. Lyu SY, Choi SH, Park WB. Korean mistletoe lectin-induced apoptosis in hepatocarcinoma cells is associated with inhibition of telomerase via mitochondrial controlled pathway independent of p53. Arch Pharm Res. 2002;25:1-7.
8. Kim MY, Vankayalapati H, Kim SY, Wierzba K, Hurley LH. Telomestatin, a potent telomerase inhibitor that interacts quite specifcally with the human telo-meric intramolecular G-quadruplex. J Am Chem Soc. 2002;124:2098-2099.
9. Togashi K, Kakeya H, Morishita M, Song YX, Osada H. Inhibition of human telomerase activity by alterperyle-nol. Oncol Res. 1998;10:449-453.
10. Tabata Y, Ikegami S, Yaguchi T, Sasaki T, Hoshiko S, Sa-kuma S, Shin-Ya K, Seto H. Diazaphilonic acid, a new azaphilone with telomerase inhibitory activity. J Anti-biot. 1999;52:412-414.
11. Lin X, Cai YJ, Li ZX, Chen Q, Liu ZL, Wang R. Structure determination, apoptosis induction, and telomerase inhibition of CFP-2, a novel lichenin from Cladonia fur-cata. Biochim Biophys Acta. 2003;1622:99-108.
12. Ueno T, Takahashi H, Oda M, Mizunuma M, Yokoyma A, Goto Y, Mizushina Y, Sakaguchi K, Hayashi H. Inhibition of human telomerase by rubromycins: implication of spiroketal system of the compounds as an active moiety. Biochemistry. 2000;39:5995-6002.
13. Togashi K, Ko HR, Ahn JS, Osada H. Inhibition of telomerase activity by fungus metabolites, CRM646-A and Thielavin B. Biosci Biotechnol Biochem. 2001;65:651-653.
14. Park SE, Yoo HS, Jin CY, Hong SH, Lee YW, Kim BW, Lee SH, Kim WJ, Cho CK, Choi YH. Induction of apop-tosis and inhibition of telomerase activity in human lung carcinoma cells by the water extract of Cordyceps milita-ris. Food Chem Toxicol. 2009;47:1667-1675.
15. Mohammad-Fata M, Hossein M, Shirin G, Ghorban-Ali H. Immunomodulating and anticancer agents in the realm of macromycetes fungi (macrofungi). Int Immuno-pharmacol. 2007;7:701-724.
16. Chatterjee S, Biswas G, Basu SK, Acharya K. Antineo-plastic effect of mushrooms: a review. Aust J Crop Sci. 2011;5(7):904-911.
17. Richardson DHS. Medicinal and other aspects of lichens. In: Galun M, ed. CRC Handbook of Lichenology, vol. 3. Boca Raton: CRC Press; 1988. pp. 93-108.
18. Müller K. Pharmaceutically relevant metabolites from lichens. Appl Microbiol Biotechnol. 2001;56:9-16.
19. Xu BJ, Sung CK, Han BH. Crystal structure characterization of natural allantoin from edible lichen Umbili-caria esculenta. Crystals. 2011;1(3):128-135.
20. Fukuoka F, Nakanishi M, Shibata S, Nishikawa Y, Take-da T, Tanaka M. Polysaccharides in lichens and fungi. II. Antitumor activity on Sarcoma-180 of the polysac-charide preparations from Gyrophora esculenta, Cetraria islandica orientalis. Gann. 1968;59:421-432.
21. Kim JW, Song KS, Chang HW, Yu SH, Bae KG, Min TJ, Yoo ID. Two phenolic compounds isolated from Um-blicaria esculenta as phospholipase A2 inhibitors. Kor J Mycol. 1996;24(3):237-242.
22. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein using the principle of protein-dye binding. Anal Biochem. 1976;72:248-254.
23. Kim NW, Wu F. Advances in quantifcation and characterization of telomerase activity by the telomeric repeat amplifcation protocol (TRAP). Nucleic Acids Res. 1997;25:2595-2597.
24. Carmichael J, Degraff WG, Gazdar AF, Minna JD, Mitchell JB. Evaluation of a tetrazolium-based semi-automated colorimetric assay: assessment of chemosensitivity testing. Cancer Res. 1987;47:936-942.
25. Bestilny LJ, Brown CB, Miura Y, Robertson LD, Riabo-wol KT. Selective inhibition of telomerase activity during terminal differentiation of immortal cell lines. Cancer Res. 1996;56:3796-3802.
26. Alfonso M Y, Cheng JQ, Kruk PA. Ultraviolet irradiation and dimethyl sulfoxide induced telomerase activity in ovarian epithelial cell lines. Exp Cell Res. 2001;267:13-27.
27. Maruyama H, Yamazaki K, Murofushi S, Konda C, Ikekawa T. Antitumor activity of Sarcodon aspratus (Berk.) S. Ito and Ganoderma lucidum (Fr.) Karst. J Pharmacobiodyn. 1989;12(2):118-123.
28. Chen Y, Hu M, Wang C, Yang Y, Chen J, Ding J, Guo W. Characterization and in vitro antitumor activity of poly-saccharides from the mycelium of Sarcodon aspratus. Int J Biol Macromol. 2013;52:52-58.